Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update

Go back to Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update
GALECTIN (NASDAQ: GALT) Delayed: 3.72 +0.01 (0.27%)
Previous Close $3.71    52 Week High $3.05 
Open $3.71    52 Week Low $0.49 
Day High $3.77    P/E N/A 
Day Low $3.68    EPS $-1.32 
Volume 60,862